English | Español

Csl Behring
Carol Ostrow | Dec 16, 2017

CSL partners with Vitaeris for organ transplant therapy
Carol Ostrow | Sep 29, 2017

CSL Behring pledges $4.92 million for Penn State biotechnology center
Erianne Leatherman | Apr 18, 2017

CSL Behring honors World Hemophilia Day with medications donation
Erianne Leatherman | Apr 14, 2017

CSL Behring awards grants to four groups to boost support for patients with rare diseases
Erianne Leatherman | Apr 12, 2017

CSL Behring to sponsor Jeffrey Modell North African Network for primary immunodeficiency
Jeff Gantt | Dec 18, 2016

Afstyla approved by Health Canada
Amanda Rupp | Jun 22, 2016

CSL Behring honors 2016 HAE Day with events
Amanda Rupp | Jun 1, 2016

Afstyla gains FDA approval as hemophilia A treatment

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’